Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?

Abstract The dichotomic nature of the adaptive immune response governs the outcome of clinical gene therapy. On the one hand, neutralizing antibodies and cytotoxic T cells can have a dramatic impact on the efficacy and safety of human gene therapies. On the other hand, regulatory T cells (Treg) can...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dimitrios L. Wagner, Lena Peter, Michael Schmueck‐Henneresse
Formato: Revisão
Lenguaje:inglés
Publicado: 2021
Acceso en línea:https://doi.org/10.1038/s41434-021-00232-2
https://www.nature.com/articles/s41434-021-00232-2.pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!